JP5218051B2 - 新規環状ペプチド化合物 - Google Patents

新規環状ペプチド化合物 Download PDF

Info

Publication number
JP5218051B2
JP5218051B2 JP2008521463A JP2008521463A JP5218051B2 JP 5218051 B2 JP5218051 B2 JP 5218051B2 JP 2008521463 A JP2008521463 A JP 2008521463A JP 2008521463 A JP2008521463 A JP 2008521463A JP 5218051 B2 JP5218051 B2 JP 5218051B2
Authority
JP
Japan
Prior art keywords
compound
salt
solution
reaction
production example
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008521463A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009513562A (ja
JP2009513562A5 (enExample
Inventor
正博 閨
誠司 吉村
一紀 上條
拓也 牧野
実 安田
敏夫 山中
栄作 辻井
幸子 山岸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of JP2009513562A publication Critical patent/JP2009513562A/ja
Publication of JP2009513562A5 publication Critical patent/JP2009513562A5/ja
Application granted granted Critical
Publication of JP5218051B2 publication Critical patent/JP5218051B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2008521463A 2005-10-26 2006-10-26 新規環状ペプチド化合物 Expired - Fee Related JP5218051B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US73001105P 2005-10-26 2005-10-26
US60/730,011 2005-10-26
US75120405P 2005-12-19 2005-12-19
US60/751,204 2005-12-19
PCT/JP2006/321924 WO2007049803A1 (en) 2005-10-26 2006-10-26 New cyclic peptide compounds

Publications (3)

Publication Number Publication Date
JP2009513562A JP2009513562A (ja) 2009-04-02
JP2009513562A5 JP2009513562A5 (enExample) 2009-11-19
JP5218051B2 true JP5218051B2 (ja) 2013-06-26

Family

ID=37847219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008521463A Expired - Fee Related JP5218051B2 (ja) 2005-10-26 2006-10-26 新規環状ペプチド化合物

Country Status (17)

Country Link
US (2) US7872097B2 (enExample)
EP (1) EP1957518B1 (enExample)
JP (1) JP5218051B2 (enExample)
KR (1) KR101273681B1 (enExample)
CN (1) CN101305019B (enExample)
AU (1) AU2006306974B2 (enExample)
BR (1) BRPI0617781A2 (enExample)
CA (1) CA2623898C (enExample)
ES (1) ES2557477T3 (enExample)
IL (1) IL190286A0 (enExample)
NO (1) NO20082354L (enExample)
PL (1) PL1957518T3 (enExample)
PT (1) PT1957518E (enExample)
RU (1) RU2423377C2 (enExample)
TW (1) TWI391403B (enExample)
WO (1) WO2007049803A1 (enExample)
ZA (1) ZA200803525B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2150269B1 (en) * 2007-05-02 2012-11-21 Astellas Pharma Inc. New cyclic peptide compounds
MX2011003259A (es) * 2008-09-24 2011-04-21 Astellas Pharma Inc Compuesto de peptido y metodo para producir el mismo.
RU2492181C2 (ru) * 2009-01-30 2013-09-10 Энанта Фармасьютикалс, Инк. Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
CN102459160A (zh) * 2009-05-15 2012-05-16 荷兰癌症研究所基金会 赖氨酸化合物和其在肽和蛋白质的位点选择性和化学选择性修饰中的用途
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
CA2785978A1 (en) * 2009-12-30 2011-07-07 Scynexis, Inc. Cyclosporine analogues
JP2015529206A (ja) 2012-08-25 2015-10-05 ザ・ジョンズ・ホプキンス・ユニバーシティ Ｇａｐｄｈカスケードインヒビター化合物ならびに使用の方法および精神病を含むストレス誘導障害の処置
WO2014049540A2 (en) 2012-09-29 2014-04-03 Novartis Ag Cyclic peptides and use as medicines
US8906853B2 (en) 2012-11-28 2014-12-09 Enanta Pharmaceuticals, Inc. [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
HK1223843A1 (zh) * 2013-08-26 2017-08-11 Enanta Pharmaceuticals, Inc. 用於預防或治療丙型肝炎的環孢菌素類似物
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271267A (ja) * 1991-04-23 1993-10-19 Fujisawa Pharmaceut Co Ltd Ｆｒ９０１４５９物質、その製法及び用途
PT1091975E (pt) 1998-07-01 2006-05-31 Debiopharm Sa Nova ciclosporina com um perfil de actividade melhorado
CA2426381A1 (en) 2000-10-19 2002-04-25 Fujisawa Pharmaceutical Co., Ltd. Cell damage inhibitor
DK1436322T3 (da) * 2001-10-19 2008-11-03 Isotechnika Inc Blandinger af cyclosporinanaloger og deres anvendelse som immunmodulerende midler
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
JP2007015926A (ja) * 2003-10-06 2007-01-25 Fujisawa Pharmaceut Co Ltd Ｃ型肝炎治療剤
PT1802650E (pt) 2004-10-01 2011-12-30 Scynexis Inc Derivados da ciclosporina 3-éter e 3-tioéter substituída para o tratamento e prevenção da infecção de hepatite c
ATE490778T1 (de) 2004-10-01 2010-12-15 Debiopharm Sa Verwendung von äd-mealaü3-äetvalü4-ciclosporin zur behandlung von hepatitis-c-infektion
ES2314731T3 (es) * 2004-11-22 2009-03-16 Astellas Pharma Inc. Analogo de ciclosporina.

Also Published As

Publication number Publication date
EP1957518A1 (en) 2008-08-20
EP1957518B1 (en) 2015-12-09
JP2009513562A (ja) 2009-04-02
RU2423377C2 (ru) 2011-07-10
CA2623898A1 (en) 2007-05-03
PL1957518T3 (pl) 2016-07-29
AU2006306974B2 (en) 2011-09-22
CN101305019B (zh) 2012-12-12
ES2557477T3 (es) 2016-01-26
PT1957518E (pt) 2016-02-26
US7872097B2 (en) 2011-01-18
CA2623898C (en) 2013-12-24
TW200732351A (en) 2007-09-01
KR101273681B1 (ko) 2013-06-25
KR20080065297A (ko) 2008-07-11
NO20082354L (no) 2008-07-01
TWI391403B (zh) 2013-04-01
ZA200803525B (en) 2009-08-26
AU2006306974A1 (en) 2007-05-03
RU2008116674A (ru) 2009-10-27
US20090170755A1 (en) 2009-07-02
US20100286033A1 (en) 2010-11-11
US8252895B2 (en) 2012-08-28
BRPI0617781A2 (pt) 2011-08-09
WO2007049803A1 (en) 2007-05-03
CN101305019A (zh) 2008-11-12
IL190286A0 (en) 2011-08-01

Similar Documents

Publication Publication Date Title
KR102794132B1 (ko) 니트릴-함유 항바이러스 화합물
US8252895B2 (en) Cyclic peptide compounds
JP5459545B2 (ja) 新規環状ペプチド化合物
CN101443350B (zh) 作为抗病剂的大环化合物
US20110218175A1 (en) Antiviral agents
TW202321251A (zh) 新穎螺環吡咯啶衍生的抗病毒劑
CN102365094A (zh) 用于预防或者治疗肝炎感染的环孢菌素类似物
TW201216979A (en) Macrocyclic proline derived HCV serine protease inhibitors
EP1893573A1 (en) Inhibitors of hcv replication
TW201119667A (en) Bismacrocyclic compounds as hepatitis C virus inhibitors
CN105579046A (zh) 用于预防或治疗丙型肝炎的环孢菌素类似物
CN106883279B (zh) 一种前药、其制备方法、药物组合物及其用途
RU2845865C2 (ru) Нитрилсодержащие противовирусные соединения
HK40073397B (en) Nitrile-containing antiviral compounds
AU2006200519A1 (en) New compound
WO2016074596A1 (zh) 核苷氨基磷酸酯衍生物及其应用
TW200927751A (en) Antiviral compounds
TW200817031A (en) Triazolyl acyclic hepatitis C serine protease inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091001

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091001

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120417

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120613

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130205

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130218

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160315

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5218051

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160315

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160315

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees